Exact Mass: 303.1735

Exact Mass Matches: 303.1735

Found 134 metabolites which its exact mass value is equals to given mass value 303.1735, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Pimelylcarnitine

(3R)-3-[(6-carboxyhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H25NO6 (303.1682)


Pimelylcarnitine is an acylcarnitine. More specifically, it is an pimelic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Pimelylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine pimelylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2,2-dimethylpentanedioylcarnitine

3-[(4-carboxy-4,4-dimethylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H25NO6 (303.1682)


2,2-dimethylpentanedioylcarnitine is an acylcarnitine. More specifically, it is an 2,2-dimethylpentanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2,2-dimethylpentanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2,2-dimethylpentanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Ethylpentanedioylcarnitine

3-[(4-carboxy-4-ethylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H25NO6 (303.1682)


2-Ethylpentanedioylcarnitine is an acylcarnitine. More specifically, it is an 2-ethylpentanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Ethylpentanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-Ethylpentanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

O-Pimeloylcarnitine

4-[(6-Carboxyhexanoyl)oxy]-4-(trimethylammonio)butanoic acid

C14H25NO6 (303.1682)


   

Aditoprim

5-{[4-(dimethylamino)-3,5-dimethoxyphenyl]methyl}pyrimidine-2,4-diamine

C15H21N5O2 (303.1695)


   

Aptiganel

N-(3-ethylphenyl)-N-methyl-N-(naphthalen-1-yl)guanidine

C20H21N3 (303.1735)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents

   

(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-methoxy-2-phenylpropanoate

(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-methoxy-2-phenylpropanoic acid

C18H25NO3 (303.1834)


   

Acetylacrifoline

Acetylacrifoline

C18H25NO3 (303.1834)


   
   

Berkeleyamide A

Berkeleyamide A

C18H25NO3 (303.1834)


   

10-O-Demethylprotoemetine

10-O-Demethylprotoemetine

C18H25NO3 (303.1834)


   

9-O-Demethylprotoemetine

9-O-Demethylprotoemetine

C18H25NO3 (303.1834)


   

3,4-Methylenedioxy PV8

3,4-Methylenedioxy PV8

C18H25NO3 (303.1834)


   

(+-)-N-Methyloreolin|(??)-Oridine|N-Methyl-oreolin|N-Methyl-oridin|N-Methyloreolin

(+-)-N-Methyloreolin|(??)-Oridine|N-Methyl-oreolin|N-Methyl-oridin|N-Methyloreolin

C18H25NO3 (303.1834)


   

dehydronitramidine

dehydronitramidine

C20H21N3 (303.1735)


   

Schoberidine

Schoberidine

C20H21N3 (303.1735)


   

(+)-mostueine|Mostueine.|mostuenine

(+)-mostueine|Mostueine.|mostuenine

C20H21N3 (303.1735)


   

(2R,2S)-3-(2,3-Dihydroxy-3-methylbutyl)-5-(2,3-epoxy-3-methylbutyl)indole

(2R,2S)-3-(2,3-Dihydroxy-3-methylbutyl)-5-(2,3-epoxy-3-methylbutyl)indole

C18H25NO3 (303.1834)


   

(-)-suaveoline|(6S,13S)-4-ethyl-6,7,12,13-tetrahydro-7-methyl-6,13-imino-5H-pyrido[3,4:5,6]cyclooct[1,2-b]indole|4-ethyl-7-methyl-6,7,12,13-tetrahydro-5H-6,13-epiazano-pyrido[3,4:5,6]cycloocta[1,2-b]indole|Suaveolin|suaveoline|Suaveoline +

(-)-suaveoline|(6S,13S)-4-ethyl-6,7,12,13-tetrahydro-7-methyl-6,13-imino-5H-pyrido[3,4:5,6]cyclooct[1,2-b]indole|4-ethyl-7-methyl-6,7,12,13-tetrahydro-5H-6,13-epiazano-pyrido[3,4:5,6]cycloocta[1,2-b]indole|Suaveolin|suaveoline|Suaveoline +

C20H21N3 (303.1735)


   

(-)-berkeleyamide A|(10S,11R,14S)-berkeleyamide A|berkeleyamide A

(-)-berkeleyamide A|(10S,11R,14S)-berkeleyamide A|berkeleyamide A

C18H25NO3 (303.1834)


   

2-[(3-isopropoy-O-beta-D-glucopyranosyl)oxy]-2-methylbutanenitrile

2-[(3-isopropoy-O-beta-D-glucopyranosyl)oxy]-2-methylbutanenitrile

C14H25NO6 (303.1682)


   
   

(-)-3-methoxy-4-O-methyljoubertiamine|(S)-3-Methoxy-4-O-methyljoubertiamine|O-methyljoubertiamine

(-)-3-methoxy-4-O-methyljoubertiamine|(S)-3-Methoxy-4-O-methyljoubertiamine|O-methyljoubertiamine

C18H25NO3 (303.1834)


   

(2E)-N-isobutyl-7-(3,4-methylenedioxy)phenylheptenenamide|(2E)-N-isobutyl-7-(3,4-methylenedioxyphenyl)hepta-2-enamide|Pipercallosidine

(2E)-N-isobutyl-7-(3,4-methylenedioxy)phenylheptenenamide|(2E)-N-isobutyl-7-(3,4-methylenedioxyphenyl)hepta-2-enamide|Pipercallosidine

C18H25NO3 (303.1834)


   

10-O-demethylproemethine|10-O-demethylprotoemetine

10-O-demethylproemethine|10-O-demethylprotoemetine

C18H25NO3 (303.1834)


   

3-hydroxy-3-nonyl-1H-quinoline-2,4-dione

3-hydroxy-3-nonyl-1H-quinoline-2,4-dione

C18H25NO3 (303.1834)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

C18H25NO3_2-Heptenamide, 7-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)-, (2E)

NCGC00347573-02_C18H25NO3_2-Heptenamide, 7-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)-, (2E)-

C18H25NO3 (303.1834)


   

tetra(methoxymethyl)melamine (putative)

tetra(methoxymethyl)melamine (putative)

[C11H23N6O4]+ (303.1781)


   
   
   
   
   
   
   
   

Atropine Methyl

Atropine Methyl

C18H25NO3 (303.1834)


   

1-O-Desmethyltetrabenazine

1-O-Desmethyltetrabenazine

C18H25NO3 (303.1834)


   

Boc-D-Glu(OtBu)-OH

Boc-D-Glu(OtBu)-OH

C14H25NO6 (303.1682)


   
   
   

TERT-BUTYL SPIRO[ISOCHROMAN-1,4-PIPERIDINE]-1-CARBOXYLATE

TERT-BUTYL SPIRO[ISOCHROMAN-1,4-PIPERIDINE]-1-CARBOXYLATE

C18H25NO3 (303.1834)


   

2,4-bis[(4-aminophenyl)methyl]aniline

2,4-bis[(4-aminophenyl)methyl]aniline

C20H21N3 (303.1735)


   

tert-Butyl 3-hydroxyspiro[indan-1,4-piperidine]-1-carboxylate

tert-Butyl 3-hydroxyspiro[indan-1,4-piperidine]-1-carboxylate

C18H25NO3 (303.1834)


   

N-Methyl-3-pyrrolidinyl Cyclopentylmandelate

N-Methyl-3-pyrrolidinyl Cyclopentylmandelate

C18H25NO3 (303.1834)


   

Boc-Glu(OtBu)-OH

Boc-Glu(OtBu)-OH

C14H25NO6 (303.1682)


   
   

2-((4-Phenylpiperazine-1-yl)methyl)quinoline

2-((4-Phenylpiperazine-1-yl)methyl)quinoline

C20H21N3 (303.1735)


   

tert-Butyl 4-(4-methylbenzoyl)piperidine-1-carboxylate

tert-Butyl 4-(4-methylbenzoyl)piperidine-1-carboxylate

C18H25NO3 (303.1834)


   

tert-Butyl 4-(5H-pyrrolo[3,2-d]pyrimidin-4-yl)piperazine-1-carboxylate

tert-Butyl 4-(5H-pyrrolo[3,2-d]pyrimidin-4-yl)piperazine-1-carboxylate

C15H21N5O2 (303.1695)


   

Methyl (8-benzyl-1-oxa-8-azaspiro[4.5]dec-2-yl)acetate

Methyl (8-benzyl-1-oxa-8-azaspiro[4.5]dec-2-yl)acetate

C18H25NO3 (303.1834)


   

(bis-tert-butoxycarbonylmethyl-amino)-acetic acid

(bis-tert-butoxycarbonylmethyl-amino)-acetic acid

C14H25NO6 (303.1682)


   

Boc-d-glu-otbu

Boc-d-glu-otbu

C14H25NO6 (303.1682)


   

3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]decan-2-one

3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]decan-2-one

C18H25NO3 (303.1834)


   

Aditoprim

Aditoprime

C15H21N5O2 (303.1695)


C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists C254 - Anti-Infective Agent > C52588 - Antibacterial Agent

   

butyl prop-2-enoate, prop-2-enamide, styrene

butyl prop-2-enoate, prop-2-enamide, styrene

C18H25NO3 (303.1834)


   

Pimelylcarnitine

Pimelylcarnitine

C14H25NO6 (303.1682)


   

2-Ethylpentanedioylcarnitine

2-Ethylpentanedioylcarnitine

C14H25NO6 (303.1682)


   

2,2-dimethylpentanedioylcarnitine

2,2-dimethylpentanedioylcarnitine

C14H25NO6 (303.1682)


   

3-Methyladipoylcarnitine

3-Methyladipoylcarnitine

C14H25NO6 (303.1682)


   

Pipercallosidine

Pipercallosidine

C18H25NO3 (303.1834)


An enamide that is (2E)-N-isobutylhept-2-enamide which is substituted at position 7 by a 3,4-methylenedioxyphenyl group. A natural product found in Piper sarmentosum.

   

Leu-Thr-Ala

Leu-Thr-Ala

C13H25N3O5 (303.1794)


A tripeptide composed of L-leucine, L-threonine and L-alanine joined in sequence by peptide linkages.

   
   
   

O-pimelylcarnitine

O-pimelylcarnitine

C14H25NO6 (303.1682)


An O-acylcarnitine in which the acyl group specified is pimelyl.

   

3-(1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)-N-propan-2-ylpyrrolidine-1-carboxamide

3-(1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)-N-propan-2-ylpyrrolidine-1-carboxamide

C15H21N5O2 (303.1695)


   

(4S)-4-(6-carboxyhexanoyloxy)-4-(trimethylazaniumyl)butanoate

(4S)-4-(6-carboxyhexanoyloxy)-4-(trimethylazaniumyl)butanoate

C14H25NO6 (303.1682)


   
   
   
   

[(2R,3R,6S)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3R,6S)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

C15H21N5O2 (303.1695)


   

[(2R,3R,6R)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3R,6R)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

C15H21N5O2 (303.1695)


   

[(2R,3S,6S)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3S,6S)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

C15H21N5O2 (303.1695)


   

[(2S,3S,6R)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2S,3S,6R)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

C15H21N5O2 (303.1695)


   
   
   
   
   
   
   
   
   
   

9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoate

9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoate

C15H27O6- (303.1808)


   

(8R)-8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoate

(8R)-8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoate

C15H27O6- (303.1808)


   

2-amino-3-methyl-4H-imidazol-5-one;2-(6-methoxy-1H-indol-3-yl)ethanamine

2-amino-3-methyl-4H-imidazol-5-one;2-(6-methoxy-1H-indol-3-yl)ethanamine

C15H21N5O2 (303.1695)


   

tetra(methoxymethyl)melamine (putative)

tetra(methoxymethyl)melamine (putative)

C11H23N6O4+ (303.1781)


   

1-Butyl-5-hydroxy-3-methoxycarbonyl-2,4,6,7-tetramethylindole

1-Butyl-5-hydroxy-3-methoxycarbonyl-2,4,6,7-tetramethylindole

C18H25NO3 (303.1834)


   

Aptiganel

Aptiganel

C20H21N3 (303.1735)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents

   

O-pimelyl-L-carnitine

O-pimelyl-L-carnitine

C14H25NO6 (303.1682)


An O-acyl-L-carnitine that is L-carnitine having a pimelyl group as the acyl substituent.

   

O-Pimeloylcarnitine

O-Pimeloylcarnitine

C14H25NO6 (303.1682)


An O-acylcarnitine having pimeloyl as the acyl substituent.

   

oscr#10(1-)

oscr#10(1-)

C15H27O6 (303.1808)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#10, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

ascr#10(1-)

ascr#10(1-)

C15H27O6 (303.1808)


A monocarboxylic acid anion resulting from the deprotonation of the carboxy group of ascr#10. The conjugate base of ascr#10 and the major species at pH 7.3.

   
   
   

n-{3-[(2s,5s)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]propyl}guanidine

n-{3-[(2s,5s)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]propyl}guanidine

C15H21N5O2 (303.1695)


   

17-ethyl-3-methyl-3,15,20-triazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8,13(18),14,16-heptaene

17-ethyl-3-methyl-3,15,20-triazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8,13(18),14,16-heptaene

C20H21N3 (303.1735)


   

(2s)-2-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-isopropoxyoxan-2-yl]oxy}-2-methylbutanenitrile

(2s)-2-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-isopropoxyoxan-2-yl]oxy}-2-methylbutanenitrile

C14H25NO6 (303.1682)


   

(1s,15r,16r,21s)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,12-hexaene

(1s,15r,16r,21s)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,12-hexaene

C20H21N3 (303.1735)


   

1-{5-[(3,3-dimethyloxiran-2-yl)methyl]-1h-indol-3-yl}-3-methylbutane-2,3-diol

1-{5-[(3,3-dimethyloxiran-2-yl)methyl]-1h-indol-3-yl}-3-methylbutane-2,3-diol

C18H25NO3 (303.1834)


   

2-{[3,5-dihydroxy-6-(hydroxymethyl)-4-isopropoxyoxan-2-yl]oxy}-2-methylbutanenitrile

2-{[3,5-dihydroxy-6-(hydroxymethyl)-4-isopropoxyoxan-2-yl]oxy}-2-methylbutanenitrile

C14H25NO6 (303.1682)


   

(2s,11bs)-2-[(2r)-1-hydroxybut-3-en-2-yl]-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-10-ol

(2s,11bs)-2-[(2r)-1-hydroxybut-3-en-2-yl]-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-10-ol

C18H25NO3 (303.1834)


   

(2s,11bs)-2-[(2s)-1-hydroxybut-3-en-2-yl]-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-10-ol

(2s,11bs)-2-[(2s)-1-hydroxybut-3-en-2-yl]-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-10-ol

C18H25NO3 (303.1834)


   

(4s)-4-[(3r,5r)-5-[(2s)-butan-2-yl]-2-hydroxy-4,5-dihydro-3h-pyrrol-3-yl]-4-hydroxy-1-phenylbutan-2-one

(4s)-4-[(3r,5r)-5-[(2s)-butan-2-yl]-2-hydroxy-4,5-dihydro-3h-pyrrol-3-yl]-4-hydroxy-1-phenylbutan-2-one

C18H25NO3 (303.1834)


   

(4s)-4-(3,4-dimethoxyphenyl)-4-[2-(dimethylamino)ethyl]cyclohex-2-en-1-one

(4s)-4-(3,4-dimethoxyphenyl)-4-[2-(dimethylamino)ethyl]cyclohex-2-en-1-one

C18H25NO3 (303.1834)


   

4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,20-hexaene

4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,20-hexaene

C20H21N3 (303.1735)


   

7-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)hept-2-enimidic acid

7-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)hept-2-enimidic acid

C18H25NO3 (303.1834)


   

(2r)-1-(5-{[(2s)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-3-yl)-3-methylbutane-2,3-diol

(2r)-1-(5-{[(2s)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-3-yl)-3-methylbutane-2,3-diol

C18H25NO3 (303.1834)


   

2-[(2r,3r,11bs)-3-ethyl-10-hydroxy-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl]acetaldehyde

2-[(2r,3r,11bs)-3-ethyl-10-hydroxy-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl]acetaldehyde

C18H25NO3 (303.1834)


   

(2e)-4-[(1s,3r,4s,7s)-4-hexyl-2-oxa-6-azatricyclo[5.3.0.0¹,³]dec-8-en-10-ylidene]but-2-enoic acid

(2e)-4-[(1s,3r,4s,7s)-4-hexyl-2-oxa-6-azatricyclo[5.3.0.0¹,³]dec-8-en-10-ylidene]but-2-enoic acid

C18H25NO3 (303.1834)


   

(2e)-7-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)hept-2-enimidic acid

(2e)-7-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)hept-2-enimidic acid

C18H25NO3 (303.1834)


   

(4s)-4-hydroxy-4-[(3r,5s)-2-hydroxy-5-(2-methylpropyl)-4,5-dihydro-3h-pyrrol-3-yl]-1-phenylbutan-2-one

(4s)-4-hydroxy-4-[(3r,5s)-2-hydroxy-5-(2-methylpropyl)-4,5-dihydro-3h-pyrrol-3-yl]-1-phenylbutan-2-one

C18H25NO3 (303.1834)


   

2-(1-hydroxybut-3-en-2-yl)-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-10-ol

2-(1-hydroxybut-3-en-2-yl)-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-10-ol

C18H25NO3 (303.1834)


   

(1r,15r,16s)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,20-hexaene

(1r,15r,16s)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,20-hexaene

C20H21N3 (303.1735)


   

(1s,10s,11r,13s,15r)-15-methyl-14-oxo-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-yl acetate

(1s,10s,11r,13s,15r)-15-methyl-14-oxo-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-yl acetate

C18H25NO3 (303.1834)


   

4-(3,4-dimethoxyphenyl)-4-[2-(dimethylamino)ethyl]cyclohex-2-en-1-one

4-(3,4-dimethoxyphenyl)-4-[2-(dimethylamino)ethyl]cyclohex-2-en-1-one

C18H25NO3 (303.1834)


   

4-hydroxy-4-[2-hydroxy-5-(2-methylpropyl)-4,5-dihydro-3h-pyrrol-3-yl]-1-phenylbutan-2-one

4-hydroxy-4-[2-hydroxy-5-(2-methylpropyl)-4,5-dihydro-3h-pyrrol-3-yl]-1-phenylbutan-2-one

C18H25NO3 (303.1834)


   

2-{3-ethyl-10-hydroxy-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl}acetaldehyde

2-{3-ethyl-10-hydroxy-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl}acetaldehyde

C18H25NO3 (303.1834)